Editorial: Case reports in respiratory pharmacology 2022

Przemyslaw Zdziarski; Luisa Ricciardi; Roberto Paganelli

doi:10.3389/fphar.2023.1242273

Editorial: Case reports in respiratory pharmacology 2022

Front Pharmacol. 2023 Aug 15:14:1242273. doi: 10.3389/fphar.2023.1242273. eCollection 2023.

Authors

Przemyslaw Zdziarski¹, Luisa Ricciardi², Roberto Paganelli³

Affiliations

¹ Department of Clinical Immunology and Pulmonary Disease, Lower Silesian Oncology, Pulmonology and Hematology Centre, Wroclaw, Poland.
² Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
³ Internal Medicine, Saint Camillus International University of Medical and Health Sciences, Rome, Italy.

No abstract available

Keywords: SARS-CoV-2; case study; corticosteroids; eosinophilic granulomatosis with polyangiitis (EGPA); off-label; patient-centered care; pharmacovigilance; respiratory pharmacology.

Publication types

Editorial